只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-28 2026-07-30 | NONE PGIM Private Credit Fund | PRUDENTIAL INSURANCE CO OF AMERICA TenPercentOwner | 卖出（S） | 214,746.359 | US$24.75 | US$531.5万 | 7,973,656.68 | SEC |
| 2026-07-28 2026-07-30 | NONE PGIM Private Credit Fund | PRUDENTIAL FINANCIAL INC TenPercentOwner | 卖出（S） | 214,746.359 | US$24.75 | US$531.5万 | 7,973,656.68 | SEC |
| 2026-07-28 2026-07-30 | NONE PGIM Private Credit Fund | PRUCO LIFE INSURANCE CO TenPercentOwner | 卖出（S） | 214,746.359 | US$24.75 | US$531.5万 | 7,973,656.68 | SEC |
| 2026-07-27 2026-07-29 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 837 | US$607.85 | US$508,770.45 | 6,290 | SEC |
| 2026-07-27 2026-07-29 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$607.85 | US$49,843.70 | 6,654 | SEC |
| 2026-07-27 2026-07-29 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 57 | US$607.85 | US$34,647.45 | 1,631 | SEC |
| 2026-07-27 2026-07-29 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$607.85 | US$49,843.70 | 6,654 | SEC |
| 2026-07-27 2026-07-29 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 408 | US$607.85 | US$248,002.80 | 80,701 | SEC |
| 2026-07-27 2026-07-29 | ROIV Roivant Sciences Ltd. | Venker Eric Officer · President & Immunovant CEO | 卖出（S） | 200,000 | US$34.95 | US$699万 | 1,613,063 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Private Multi-Asset Credit & Income Fund TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Private Credit Strategies LLC TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Holdings I L.P. TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Holdings I/II GP L.L.C. TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Inc. TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Group Management L.L.C. TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-24 | NONE Blackstone Private Real Estate Credit & Income Fund | SCHWARZMAN STEPHEN A TenPercentOwner | 买入（P） | 573,613.767 | US$26.15 | US$1500万 | 8,455,758.36 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-23 | N/A BlackRock Private Investments Fund | Mian Arslan Hameed Other | 买入（P） | 9,980.04 | US$15.03 | US$150,000.00 | 9,980.04 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-20 2026-07-22 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 837 | US$645.85 | US$540,576.45 | 7,127 | SEC |
| 2026-07-20 2026-07-22 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$645.85 | US$52,959.70 | 6,736 | SEC |
| 2026-07-20 2026-07-22 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 57 | US$645.85 | US$36,813.45 | 1,688 | SEC |
| 2026-07-20 2026-07-22 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$645.85 | US$52,959.70 | 6,736 | SEC |
| 2026-07-20 2026-07-22 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 408 | US$645.85 | US$263,506.80 | 81,109 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-15 2026-07-16 | VANI Vivani Medical, Inc. | Williams Gregg Director,TenPercentOwner | 买入（P） | 793,650 | US$1.26 | US$999,999.00 | 36,912,736 | SEC |
| 2026-07-13 2026-07-15 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 1,534 | US$660.98 | US$101.39万 | 7,964 | SEC |
| 2026-07-13 2026-07-15 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$661.13 | US$54,212.66 | 6,818 | SEC |
| 2026-07-13 2026-07-15 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 57 | US$661.13 | US$37,684.41 | 1,745 | SEC |
| 2026-07-13 2026-07-15 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 82 | US$661.13 | US$54,212.66 | 6,818 | SEC |
| 2026-07-13 2026-07-15 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 408 | US$661.13 | US$269,741.04 | 81,517 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 22,757 | US$28.60 | US$650,895.71 | 135,098 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 4,413 | US$29.82 | US$131,615.96 | 130,685 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 830 | US$30.31 | US$25,160.29 | 129,855 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 2,076 | US$600.40 | US$124.64万 | 10,770 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 816 | US$601.45 | US$490,779.45 | 9,954 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 376 | US$602.63 | US$226,588.28 | 9,578 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 80 | US$603.14 | US$48,251.20 | 9,498 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 246 | US$600.00 | US$147,600.00 | 6,900 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 171 | US$600.00 | US$102,600.00 | 1,802 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 246 | US$600.00 | US$147,600.00 | 6,900 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 736 | US$600.32 | US$441,834.71 | 82,413 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 314 | US$601.44 | US$188,853.04 | 82,099 | SEC |
| 2026-07-06 2026-07-08 | META Meta Platforms, Inc. | Olivan Javier Officer · Chief Operating Officer | 卖出（S） | 174 | US$602.75 | US$104,877.91 | 81,925 | SEC |
| 2026-07-02 2026-07-07 | NONE Privacore VPC Asset Backed Credit Fund | Corbin Capital Partners, L.P. TenPercentOwner | 买入（P） | 247,279.921 | US$10.11 | US$250万 | 3,475,196.793 | SEC |
| 2026-07-02 2026-07-07 | NONE Privacore VPC Asset Backed Credit Fund | Corbin Capital Partners GP, LLC TenPercentOwner | 买入（P） | 247,279.921 | US$10.11 | US$250万 | 3,475,196.793 | SEC |
| 2026-07-02 2026-07-07 | NONE Privacore VPC Asset Backed Credit Fund | CCP 575 Investment Accelerator, LLC TenPercentOwner | 买入（P） | 247,279.921 | US$10.11 | US$250万 | 3,475,196.793 | SEC |
| 2026-07-02 2026-07-07 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio Director | 卖出（S） | 3,000 | US$40.00 | US$120,000.00 | 19,225 | SEC |
| 2026-07-02 2026-07-07 | FTECX First Trust Enhanced Private Credit Fund | CHAD EISENBERG Officer · TREASURER | 买入（P） | 42,461.78 | US$9.42 | US$399,989.97 | 42,461.78 | SEC |
| 2026-07-02 2026-07-07 | FTECX First Trust Enhanced Private Credit Fund | PECK MICHAEL D Officer · PRESIDENT | 买入（P） | 159,234.61 | US$9.42 | US$150万 | 159,234.61 | SEC |
| 2026-07-02 2026-07-06 | CDLX Cardlytics, Inc. | Lynton Nicholas Hollmeyer Officer · Chief Legal & Privacy Officer | 卖出（S） | 2,151 | US$4.40 | US$9,453.64 | 19,353 | SEC |
| 2026-07-01 2026-07-06 | SEZL Sezzle Inc. | Sabzivand Amin Officer · Chief Operating Officer | 卖出（S） | 3,837 | US$179.59 | US$689,082.99 | 262,873 | SEC |
| 2026-07-01 2026-07-06 | SEZL Sezzle Inc. | Sabzivand Amin Officer · Chief Operating Officer | 卖出（S） | 3,093 | US$180.31 | US$557,699.14 | 259,780 | SEC |
| 2026-07-01 2026-07-02 | N/A Partners Group Private Equity Fund, LLC | Goodstein Ruth S Other | 买入（P） | 11,387.965 | US$2.20 | US$25,053.52 | — | SEC |
| 2026-07-01 2026-07-02 | N/A Partners Group Private Equity Fund, LLC | Hood Lewis Randolph Jr Other | 买入（P） | 227,759.304 | US$2.20 | US$501,070.47 | — | SEC |
| 2026-06-30 2026-07-20 | N/A Keystone Private Income Fund | Mattson Michelle Ann Officer · Secretary | 卖出（S） | 362.615 | US$97.90 | US$35,500.01 | 2,302.553 | SEC |
| 2026-06-30 2026-07-20 | N/A Keystone Private Income Fund | Mattson Michelle Ann Officer · Secretary | 卖出（S） | 102.145 | US$97.90 | US$10,000.00 | 95.748 | SEC |
| 2026-06-30 2026-07-02 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan Director | 卖出（S） | 10,000 | US$34.90 | US$349,000.00 | 42,963 | SEC |
| 2026-06-30 2026-06-30 | ROIV Roivant Sciences Ltd. | QVT Financial LP Other | 卖出（S） | 12,380 | US$35.28 | US$436,766.40 | 13,689,166 | SEC |
| 2026-06-30 2026-06-30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen Director | 卖出（S） | 12,380 | US$35.28 | US$436,766.40 | 13,689,166 | SEC |
| 2026-06-30 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 200,000 | US$35.45 | US$709万 | 1,748,403 | SEC |
| 2026-06-30 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 12,380 | US$35.28 | US$436,766.40 | 13,689,166 | SEC |
| 2026-06-29 2026-07-01 | NONE Blackstone Private Equity Strategies Fund L.P. | Morrison Thomas M Officer · President | 买入（P） | 78.806 | US$38.07 | US$2,999.99 | 39,479.984 | SEC |
| 2026-06-29 2026-07-01 | NONE Blackstone Private Equity Strategies Fund L.P. | Solotar Joan Director | 买入（P） | 4,544.487 | US$38.07 | US$172,999.99 | 211,207.152 | SEC |
| 2026-06-29 2026-07-01 | NONE Blackstone Private Equity Strategies Fund L.P. | James Christopher J. Director,Officer · Chairperson | 买入（P） | 459.702 | US$38.07 | US$17,499.98 | 16,126.605 | SEC |
| 2026-06-29 2026-07-01 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, Director | 卖出（S） | 15,002 | US$34.32 | US$514,868.64 | 19,222 | SEC |
| 2026-06-29 2026-07-01 | ROIV Roivant Sciences Ltd. | Epperly Melissa B, Director | 卖出（S） | 2,748 | US$34.71 | US$95,383.08 | 16,474 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | QVT Financial LP Other | 卖出（S） | 600,000 | US$34.59 | US$2075.4万 | 13,701,546 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | QVT Financial LP Other | 卖出（S） | 200,000 | US$34.44 | US$688.8万 | 14,301,546 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen Director | 卖出（S） | 200,000 | US$34.44 | US$688.8万 | 14,301,546 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen Director | 卖出（S） | 600,000 | US$34.59 | US$2075.4万 | 13,701,546 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 600,000 | US$34.59 | US$2075.4万 | 13,701,546 | SEC |
| 2026-06-29 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 200,000 | US$34.44 | US$688.8万 | 14,301,546 | SEC |
| 2026-06-29 2026-06-30 | NONE TCW Private Asset Income Fund | Tarica Andrew Director | 买入（P） | 1,132.38 | US$9.99 | US$11,312.48 | 57,804.72 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | QVT Financial LP Other | 卖出（S） | 325,000 | US$34.07 | US$1107.28万 | 14,501,546 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | QVT Financial LP Other | 卖出（S） | 300,783 | US$33.92 | US$1020.26万 | 14,826,546 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen Director | 卖出（S） | 325,000 | US$34.07 | US$1107.28万 | 14,501,546 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | Gold Daniel Allen Director | 卖出（S） | 300,783 | US$33.92 | US$1020.26万 | 14,826,546 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 325,000 | US$34.07 | US$1107.28万 | 14,501,546 | SEC |
| 2026-06-26 2026-06-30 | ROIV Roivant Sciences Ltd. | MANCHESTER KEITH S Director | 卖出（S） | 300,783 | US$33.92 | US$1020.26万 | 14,826,546 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh Director,Officer · President & CIO | 卖出（S） | 500,000 | US$34.08 | US$1704万 | 18,677,617 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ROIV Roivant Sciences Ltd. | Sukhatme Mayukh Director,Officer · President & CIO | 卖出（S） | 500,000 | US$34.13 | US$1706.5万 | 18,677,617 | SEC |
| 2026-06-25 2026-06-26 | DFTX Definium Therapeutics, Inc. | Sullivan Mark Officer · Chief Legal Officer | 卖出（S） | 13,008 | US$45.03 | US$585,750.24 | 320,571 | SEC |
| 2026-06-24 2026-06-26 | ROIV Roivant Sciences Ltd. | Venker Eric Officer · President & Immunovant CEO | 卖出（S） | 46,234 | US$33.51 | US$154.93万 | 1,613,063 | SEC |
| 2026-06-24 2026-06-26 | ROIV Roivant Sciences Ltd. | Venker Eric Officer · President & Immunovant CEO | 卖出（S） | 153,766 | US$33.05 | US$508.2万 | 1,659,297 | SEC |
| 2026-06-23 2026-06-24 | TAKAX Carlyle Tactical Private Credit Fund | THRIVENT FINANCIAL FOR LUTHERANS Other | 买入（P） | 200,000 | US$25.00 | US$500万 | 200,000 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Holdings I L.P. TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | SCHWARZMAN STEPHEN A TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Private Multi-Asset Credit & Income Fund TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Private Credit Strategies LLC TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Holdings I/II GP L.L.C. TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Group Management L.L.C. TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-23 2026-06-24 | NONE Blackstone Private Real Estate Credit & Income Fund | Blackstone Inc. TenPercentOwner | 买入（P） | 765,110.94 | US$26.14 | US$2000万 | 7,882,144.59 | SEC |
| 2026-06-22 2026-06-25 | NONE Privacore PCAAM Alternative Income Fund | JANUS HENDERSON INVESTORS US LLC TenPercentOwner | 卖出（S） | 280,000 | US$10.36 | US$290.08万 | 2,520,000 | SEC |
| 2026-06-22 2026-06-24 | NONE Privacore PCAAM Alternative Income Fund | JANUS HENDERSON INVESTORS US LLC TenPercentOwner | 卖出（S） | 280,000 | US$10.36 | US$290.08万 | 2,520,000 | SEC |
| 2026-06-22 2026-06-24 | NONE Fortress Private Lending Fund | Blanchette Aaron Thomas Director,Officer · Co-Chief Executive Officer | 买入（P） | 20,723 | US$24.13 | US$500,045.99 | 20,723 | SEC |
| 2026-06-22 2026-06-24 | NONE AB Commercial Real Estate Private Debt Fund, LLC | Brogan Marguerite Director | 买入（P） | 0 | US$0.00 | US$0.00 | 9,246.66 | SEC |
| 2026-06-22 2026-06-24 | NONE AB Commercial Real Estate Private Debt Fund, LLC | Gordon Peter Director | 买入（P） | 0 | US$0.00 | US$0.00 | 10,878.74 | SEC |
| 2026-06-22 2026-06-24 | NONE AB Commercial Real Estate Private Debt Fund, LLC | Gellert Edward Director | 买入（P） | 0 | US$0.00 | US$0.00 | 5,919.43 | SEC |
| 2026-06-18 2026-06-22 | OFIX Orthofix Medical Inc. | McPherron Aviva Officer · Pres, Global Ops & Qual | 卖出（S） | 3,670 | US$9.38 | US$34,424.60 | 66,330 | SEC |
| 2026-06-16 2026-06-18 | NONE Stellus Private Credit BDC | D'Angelo Dean Other | 买入（P） | 1,224 | US$15.12 | US$18,506.88 | 24,754 | SEC |
| 2026-06-16 2026-06-18 | NONE Stellus Private Credit BDC | Ladd Robert T. Officer,Other · CEO and President | 买入（P） | 1,469 | US$15.12 | US$22,211.28 | 39,681.85 | SEC |
| 2026-06-16 2026-06-18 | NONE Stellus Private Credit BDC | Huskinson W. Todd Officer · CFO, CCO and Secretary | 买入（P） | 218 | US$15.12 | US$3,296.16 | 5,707.05 | SEC |
| 2026-06-16 2026-06-18 | STRUX StepStone Private Infrastructure Fund | StepStone Group LP TenPercentOwner | 卖出（S） | 1,007.2 | US$15.57 | US$15,682.10 | 0 | SEC |
| 2026-06-16 2026-06-18 | STRUX StepStone Private Infrastructure Fund | StepStone Group LP TenPercentOwner | 卖出（S） | 274,528.47 | US$15.62 | US$428.81万 | 0 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,222 | US$507.43 | US$214.24万 | 6,829,166.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 2,156 | US$508.50 | US$109.63万 | 6,827,010.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,523 | US$509.54 | US$332.37万 | 6,820,487.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,456 | US$510.43 | US$329.53万 | 6,814,031.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,177 | US$511.59 | US$316.01万 | 6,807,854.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 153 | US$494.84 | US$75,710.52 | 6,948,844.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 3,754 | US$495.49 | US$186.01万 | 6,945,090.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,695 | US$496.49 | US$233.1万 | 6,940,395.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 13,628 | US$497.50 | US$677.99万 | 6,926,767.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 19,421 | US$498.52 | US$968.18万 | 6,907,346.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 17,871 | US$499.46 | US$892.58万 | 6,889,475.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 10,683 | US$512.54 | US$547.55万 | 6,797,171.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,260 | US$513.39 | US$270.04万 | 6,791,911.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,311 | US$514.35 | US$273.17万 | 6,786,600.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 408 | US$515.14 | US$210,177.12 | 6,786,192.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 100 | US$516.81 | US$51,681.00 | 6,786,092.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 70 | US$517.60 | US$36,232.00 | 6,786,022.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 547 | US$518.22 | US$283,466.34 | 6,785,475.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 40 | US$519.50 | US$20,780.00 | 6,785,435.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 348 | US$520.30 | US$181,064.40 | 6,785,087.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 4,869 | US$500.39 | US$243.64万 | 6,884,606.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 5,895 | US$501.43 | US$295.59万 | 6,878,711.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 6,991 | US$502.61 | US$351.37万 | 6,871,720.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 11,122 | US$503.50 | US$559.99万 | 6,860,598.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 9,693 | US$504.42 | US$488.93万 | 6,850,905.25 | SEC |
| 2026-06-16 2026-06-18 | APP AppLovin Corp | Vivas Eduardo Director | 卖出（S） | 9,319 | US$505.46 | US$471.04万 | 6,841,586.25 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| FIVA | 25,312.0862 | 0 | 37,317.8567 | 67.83% | Q, N |
| IVA | 170,338 | 250 | 449,139.5359 | 37.93% | B, Q, N |
| IVAL | 2,888.0203 | 0 | 8,166.3 | 35.37% | Q, N |